Back to Journals » OncoTargets and Therapy » Volume 6

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Total article views   Abstract views HTML views PDF downloads Totals
12,634 Dovepress* 8,016 730+ 2,689 8,746
PubMed Central* 10 3,878 1,545 3,888
Totals 8,026 4,608 4,234 12,634
*Since 5 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar